Progression of kidney disease in non-diabetic patients with coronary artery disease: predictive role of circulating matrix metalloproteinase-2, -3, and -9.
BACKGROUND: Circulating matrix metalloproteinase (MMP)-2, -3 and -9 are well recognized in predicting cardiovascular outcome in coronary artery disease (CAD), but their risks for chronic kidney disease (CKD) are lacking. Therefore, the present study aimed to investigate whether circulating MMP level...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3724836?pdf=render |
| _version_ | 1818318333510942720 |
|---|---|
| author | Ta-Wei Hsu Ko-Lin Kuo Szu-Chun Hung Po-Hsun Huang Jaw-Wen Chen Der-Cherng Tarng |
| author_facet | Ta-Wei Hsu Ko-Lin Kuo Szu-Chun Hung Po-Hsun Huang Jaw-Wen Chen Der-Cherng Tarng |
| author_sort | Ta-Wei Hsu |
| collection | DOAJ |
| description | BACKGROUND: Circulating matrix metalloproteinase (MMP)-2, -3 and -9 are well recognized in predicting cardiovascular outcome in coronary artery disease (CAD), but their risks for chronic kidney disease (CKD) are lacking. Therefore, the present study aimed to investigate whether circulating MMP levels could independently predict future kidney disease progression in non-diabetic CAD patients. METHODS: The prospective study enrolled 251 non-diabetic subjects referred for coronary angiography, containing normal coronary artery (n = 30) and CAD with insignificant (n = 95) and significant (n = 126) stenosis. Estimated glomerular filtration rate (eGFR) was calculated using the CKD-EPI formula. eGFR decline rate was calculated and the primary endpoint was a decline in eGFR over 25% from baseline. RESULTS: The eGFR decline rate (ml/min/1.73 m(2) per year) in patients with CAD (1.22 [-1.27, 1.05]) was greater than that in those with normal coronary artery (0.21 [-2.63, 0.47], P<0.01). The circulating MMP-2, -3 and -9 were independently associated with faster eGFR decline among CAD patients. The mean follow-up period was 8.5±2.4 years, and 39 patients reached the primary endpoint. In multivariate Cox regression model, the adjusted hazard ratios of MMP-2 ≥861 ng/mL, MMP-3 ≥227 ng/mL and MMP-9 ≥49 ng/mL for predicting CKD progression were 2.47 (95% CI, 1.21 to 5.07), 2.15 (1.12 to 4.18), and 4.71 (2.14 to 10.4), respectively. While added to a model of conventional risk factors and baseline eGFR, MMP-2, -3 and -9 further significantly improved the model predictability for CKD progression (c statistic, 0.817). In the sensitivity analyses, the results were similar no matter if we changed the endpoints of a decline of >20% in eGFR from baseline or final eGFR < 60 mL/min/1.73 m(2). CONCLUSION: Circulating MMP-2, -3 and -9 are independently associated with kidney disease progression in non-diabetic CAD patients and add incremental predictive power to conventional risk factors. |
| first_indexed | 2024-12-13T09:51:33Z |
| format | Article |
| id | doaj.art-2addb4b24ea74335862044f9dce7e3d4 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-13T09:51:33Z |
| publishDate | 2013-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-2addb4b24ea74335862044f9dce7e3d42022-12-21T23:51:54ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0187e7013210.1371/journal.pone.0070132Progression of kidney disease in non-diabetic patients with coronary artery disease: predictive role of circulating matrix metalloproteinase-2, -3, and -9.Ta-Wei HsuKo-Lin KuoSzu-Chun HungPo-Hsun HuangJaw-Wen ChenDer-Cherng TarngBACKGROUND: Circulating matrix metalloproteinase (MMP)-2, -3 and -9 are well recognized in predicting cardiovascular outcome in coronary artery disease (CAD), but their risks for chronic kidney disease (CKD) are lacking. Therefore, the present study aimed to investigate whether circulating MMP levels could independently predict future kidney disease progression in non-diabetic CAD patients. METHODS: The prospective study enrolled 251 non-diabetic subjects referred for coronary angiography, containing normal coronary artery (n = 30) and CAD with insignificant (n = 95) and significant (n = 126) stenosis. Estimated glomerular filtration rate (eGFR) was calculated using the CKD-EPI formula. eGFR decline rate was calculated and the primary endpoint was a decline in eGFR over 25% from baseline. RESULTS: The eGFR decline rate (ml/min/1.73 m(2) per year) in patients with CAD (1.22 [-1.27, 1.05]) was greater than that in those with normal coronary artery (0.21 [-2.63, 0.47], P<0.01). The circulating MMP-2, -3 and -9 were independently associated with faster eGFR decline among CAD patients. The mean follow-up period was 8.5±2.4 years, and 39 patients reached the primary endpoint. In multivariate Cox regression model, the adjusted hazard ratios of MMP-2 ≥861 ng/mL, MMP-3 ≥227 ng/mL and MMP-9 ≥49 ng/mL for predicting CKD progression were 2.47 (95% CI, 1.21 to 5.07), 2.15 (1.12 to 4.18), and 4.71 (2.14 to 10.4), respectively. While added to a model of conventional risk factors and baseline eGFR, MMP-2, -3 and -9 further significantly improved the model predictability for CKD progression (c statistic, 0.817). In the sensitivity analyses, the results were similar no matter if we changed the endpoints of a decline of >20% in eGFR from baseline or final eGFR < 60 mL/min/1.73 m(2). CONCLUSION: Circulating MMP-2, -3 and -9 are independently associated with kidney disease progression in non-diabetic CAD patients and add incremental predictive power to conventional risk factors.http://europepmc.org/articles/PMC3724836?pdf=render |
| spellingShingle | Ta-Wei Hsu Ko-Lin Kuo Szu-Chun Hung Po-Hsun Huang Jaw-Wen Chen Der-Cherng Tarng Progression of kidney disease in non-diabetic patients with coronary artery disease: predictive role of circulating matrix metalloproteinase-2, -3, and -9. PLoS ONE |
| title | Progression of kidney disease in non-diabetic patients with coronary artery disease: predictive role of circulating matrix metalloproteinase-2, -3, and -9. |
| title_full | Progression of kidney disease in non-diabetic patients with coronary artery disease: predictive role of circulating matrix metalloproteinase-2, -3, and -9. |
| title_fullStr | Progression of kidney disease in non-diabetic patients with coronary artery disease: predictive role of circulating matrix metalloproteinase-2, -3, and -9. |
| title_full_unstemmed | Progression of kidney disease in non-diabetic patients with coronary artery disease: predictive role of circulating matrix metalloproteinase-2, -3, and -9. |
| title_short | Progression of kidney disease in non-diabetic patients with coronary artery disease: predictive role of circulating matrix metalloproteinase-2, -3, and -9. |
| title_sort | progression of kidney disease in non diabetic patients with coronary artery disease predictive role of circulating matrix metalloproteinase 2 3 and 9 |
| url | http://europepmc.org/articles/PMC3724836?pdf=render |
| work_keys_str_mv | AT taweihsu progressionofkidneydiseaseinnondiabeticpatientswithcoronaryarterydiseasepredictiveroleofcirculatingmatrixmetalloproteinase23and9 AT kolinkuo progressionofkidneydiseaseinnondiabeticpatientswithcoronaryarterydiseasepredictiveroleofcirculatingmatrixmetalloproteinase23and9 AT szuchunhung progressionofkidneydiseaseinnondiabeticpatientswithcoronaryarterydiseasepredictiveroleofcirculatingmatrixmetalloproteinase23and9 AT pohsunhuang progressionofkidneydiseaseinnondiabeticpatientswithcoronaryarterydiseasepredictiveroleofcirculatingmatrixmetalloproteinase23and9 AT jawwenchen progressionofkidneydiseaseinnondiabeticpatientswithcoronaryarterydiseasepredictiveroleofcirculatingmatrixmetalloproteinase23and9 AT dercherngtarng progressionofkidneydiseaseinnondiabeticpatientswithcoronaryarterydiseasepredictiveroleofcirculatingmatrixmetalloproteinase23and9 |